Lipocine Inc. 4
4 · Lipocine Inc. · Filed Jan 7, 2016
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-01-05$12.92/sh+40,000$516,800→ 40,000 totalExercise: $12.92From: 2017-01-05Exp: 2026-01-05→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 5, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years